{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:29:53Z","timestamp":1781141393015,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00105-021-04931-0","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T14:02:53Z","timestamp":1639490573000},"page":"156-159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Erythroderme Psoriasis nach COVID-19-Erkrankung","Erythrodermic psoriasis after COVID-19"],"prefix":"10.1007","volume":"73","author":[{"given":"Jeta","family":"Demiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsianakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"issue":"6","key":"4931_CR1","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon\u00a0A, Sch\u00e4kel\u00a0K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20(6):1475","journal-title":"Int J Mol Sci"},{"key":"4931_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/PTT.S126727","volume":"7","author":"DM Balak","year":"2017","unstructured":"Balak\u00a0DM, Hajdarbegovic\u00a0E (2017) Drug-induced psoriasis: clinical perspectives. Psoriasis 7:87\u201394","journal-title":"Psoriasis"},{"key":"4931_CR3","first-page":"32","volume":"3","author":"GK Kim","year":"2010","unstructured":"Kim\u00a0GK, Del Rosso\u00a0JQ (2010) Drug-provoked psoriasis: Is it drug induced or drug aggravated?: Understanding pathophysiology and clinical relevance. J\u00a0Clin Aesthet Dermatol 3:32\u201338","journal-title":"J Clin Aesthet Dermatol"},{"key":"4931_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fcimb.2019.00007","volume":"9","author":"MJE Visser","year":"2019","unstructured":"Visser\u00a0MJE, Kell\u00a0DB, Pretorius\u00a0E (2019) Bacterial dysbiosis and translocation in psoriasis vulgaris. Front Cell Infect Microbiol 9:7","journal-title":"Front Cell Infect Microbiol"},{"key":"4931_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/108729100317696","volume":"14","author":"E Mallon","year":"2000","unstructured":"Mallon\u00a0E, Bunker\u00a0CB (2000) HIV-associated psoriasis. AIDS Patient Care STDS 14:239\u2013246","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"4931_CR6","first-page":"e13383","volume":"33","author":"\u00d6 Kutlu","year":"2020","unstructured":"Kutlu \u00d6, Metin\u00a0A (2020) A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a\u00a0patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic? Dermatol Ther 33(4):e13383","journal-title":"Dermatol Ther"},{"issue":"4","key":"4931_CR7","doi-asserted-by":"publisher","first-page":"e13632","DOI":"10.1111\/dth.13632","volume":"33","author":"R Ozaras","year":"2020","unstructured":"Ozaras\u00a0R, Berk\u00a0A, Ucar\u00a0DH et al (2020) Covid-19 and exacerbation of psoriasis. Dermatol Ther 33(4):e13632","journal-title":"Dermatol Ther"},{"issue":"5","key":"4931_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/09546634.2020.1764904","volume":"31","author":"S Nasiri","year":"2020","unstructured":"Nasiri\u00a0S, Araghi\u00a0F, Tabary\u00a0M et al (2020) A challenging case of psoriasis flare-up after COVID-19 infection. J\u00a0Dermatolog Treat 31(5):448\u2013449","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"4931_CR9","doi-asserted-by":"crossref","first-page":"e04568","DOI":"10.1002\/ccr3.4568","volume":"9","author":"A Elrazi","year":"2021","unstructured":"Elrazi\u00a0A, Abdelaziz\u00a0M, Joud\u00a0A et al (2021) SARS-CoV\u20112 and guttate psoriasis: a case report and review of literature. Clin Case Rep 9(7):e4568","journal-title":"Clin Case Rep"},{"issue":"8","key":"4931_CR10","first-page":"815","volume":"18","author":"T Buhl","year":"2020","unstructured":"Buhl\u00a0T, Beissert\u00a0S, Gaffal\u00a0E et al (2020) COVID-19 und Auswirkungen auf dermatologische und allergologische Erkrankungen. J\u00a0Dtsch Dermatol Ges 18(8):815\u2013825","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"4931_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41590-021-00901-9","volume":"22","author":"M Buszko","year":"2021","unstructured":"Buszko\u00a0M, Nita-Lazar\u00a0A, Park\u00a0J\u2011H et al (2021) (2021) Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol 22(4):404\u2013411","journal-title":"Nat Immunol"},{"issue":"10251","key":"4931_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0140-6736(20)31754-2","volume":"396","author":"D Jamiolkowski","year":"2020","unstructured":"Jamiolkowski\u00a0D, M\u00fchleisen\u00a0B, M\u00fcller\u00a0S et al (2020) SARS-CoV\u20112 PCR testing of skin for COVID-19 diagnostics: a\u00a0case report. Lancet 396(10251):598\u2013599","journal-title":"Lancet"},{"key":"4931_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","volume":"11","author":"D Ragab","year":"2020","unstructured":"Ragab\u00a0D, Salah Eldin\u00a0H, Taeimah\u00a0M et al (2020) The COVID-19 Cytokine storm; what we know so far. Front Immunol 11:1446","journal-title":"Front Immunol"},{"key":"4931_CR14","first-page":"e13509","volume":"33","author":"\u00d6 Kutlu","year":"2020","unstructured":"Kutlu \u00d6, Metin\u00a0A (2020) Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? Dermatol Ther 33:e13509","journal-title":"Dermatol Ther"},{"key":"4931_CR15","doi-asserted-by":"publisher","first-page":"e13434","DOI":"10.1111\/dth.13434","volume":"33","author":"P Amerio","year":"2020","unstructured":"Amerio\u00a0P, Prignano\u00a0F, Giuliani\u00a0F et al (2020) COVID-19 and psoriasis: Should we fear for patients treated with biologics? Dermatol Ther 33:e13434","journal-title":"Dermatol Ther"},{"issue":"6","key":"4931_CR16","first-page":"e13858","volume":"33","author":"\u00d6F Elmas","year":"2020","unstructured":"Elmas \u00d6F, Demirba\u015f\u00a0A, Kutlu \u00d6 et al (2020) Psoriasis and COVID-19: A narrative review with treatment considerations. Dermatol Ther 33(6):e13858","journal-title":"Dermatol Ther"},{"issue":"1","key":"4931_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaci.2020.10.007","volume":"147","author":"SK Mahil","year":"2021","unstructured":"Mahil\u00a0SK, Dand\u00a0N, Mason\u00a0KJ et al (2021) Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a\u00a0global registry-based study. J\u00a0Allergy Clin Immunol 147(1):60\u201371","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"4931_CR18","first-page":"e173","volume":"35","author":"LEM de Wijs","year":"2021","unstructured":"de Wijs\u00a0LEM, Joustra\u00a0MM, Olydam\u00a0JI et al (2021) COVID-19 in patients with cutaneous immune-mediated diseases in The Netherlands: real-world observational data. J\u00a0Eur Acad Dermatol Venereol 35(3):e173\u2013e176","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4931_CR19","unstructured":"Wu JJ, Liu J, Thatiparthi A et al (2021) Association between systemic treatments and COVID-19 infection risk in patients with psoriasis. https:\/\/www.aad.org\/member\/meetings-education\/aadvmx (Virtueller Kongress der American Academy of Dermatology, Late Breaker Session 24.04.2021). Zugegriffen: 22.\u00a0Juni 2021"},{"key":"4931_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1789051","volume":"6","author":"A Ebrahimi","year":"2020","unstructured":"Ebrahimi\u00a0A, Sayad\u00a0B, Rahimi\u00a0Z (2020) COVID-19 and psoriasis: biologic treatment and challenges. J\u00a0Dermatolog Treat 6:1\u20135. https:\/\/doi.org\/10.1080\/09546634.2020.1789051 (PMID: 32598204)","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"4931_CR21","first-page":"e14684","volume":"34","author":"P Mungu\u00eda-Calzada","year":"2020","unstructured":"Mungu\u00eda-Calzada\u00a0P, Drake-Monfort\u00a0M, Armesto\u00a0S et al (2020) Psoriasis flare after influenza vaccination in Covid-19 era: a report of four cases from a\u00a0single center. Dermatol Ther 34(1):e14684","journal-title":"Dermatol Ther"},{"key":"4931_CR22","unstructured":"Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https:\/\/derma.de\/corona\/impfung-gegen-sars-cov-2\/. Zugegriffen: 13.\u00a0Dez. 2021"},{"key":"4931_CR23","unstructured":"Stellungnahme der Deutschen Dermatologischen Gesellschaft zum Thema COVID-19 Vakzinierung unter Systemtherapie. https:\/\/dgrh.de\/Start\/Wissenschaft\/Forschung\/COVID-19.html. Zugegriffen: 13.\u00a0Dez. 2021"},{"issue":"2","key":"4931_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaad.2020.05.074","volume":"83","author":"M Sachdeva","year":"2020","unstructured":"Sachdeva\u00a0M, Mufti\u00a0A, Maliyar\u00a0K et al (2020) Hydroxychloroquine effects on psoriasis: A systematic review and a\u00a0cautionary note for COVID-19 treatment. J\u00a0Am Acad Dermatol 83(2):579\u2013586","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4931_CR25","doi-asserted-by":"publisher","first-page":"e14691","DOI":"10.1111\/dth.14691","volume":"34","author":"A Kara Polat","year":"2021","unstructured":"Kara Polat\u00a0A, Oguz Topal\u00a0I, Karadag\u00a0AS et al (2021) The impact of COVID-19 in patients with psoriasis: a multicenter study in Istanbul. Dermatol Ther 34(1):e14691","journal-title":"Dermatol Ther"},{"issue":"8","key":"4931_CR26","doi-asserted-by":"publisher","first-page":"e237367","DOI":"10.1136\/bcr-2020-237367","volume":"13","author":"K Gananandan","year":"2020","unstructured":"Gananandan\u00a0K, Sacks\u00a0B, Ewing\u00a0I (2020) Guttate psoriasis secondary to COVID-19. BMJ Case Rep 13(8):e237367","journal-title":"BMJ Case Rep"},{"issue":"3","key":"4931_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/ijd.12231","volume":"53","author":"A Gravani","year":"2014","unstructured":"Gravani\u00a0A, Gaitanis\u00a0G, Zioga\u00a0A et al (2014) Synthetic antimalarial drugs and the triggering of psoriasis do we need disease-specific guidelines for the management of patients with psoriasis at risk of malaria? Int J Dermatol 53(3):327\u2013330","journal-title":"Int J Dermatol"},{"issue":"12","key":"4931_CR28","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.4049\/jimmunol.1303276","volume":"193","author":"A Said","year":"2014","unstructured":"Said\u00a0A, Bock\u00a0S, Lajqi\u00a0T et al (2014) Chloroquine promotes IL-17 production by CD41 T cells via p38- dependent IL-23 release by monocyte-derived Langerhanslike cells. J\u00a0Immunol 193(12):6135\u20136143","journal-title":"J Immunol"},{"key":"4931_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17582","author":"E Sotiriou","year":"2021","unstructured":"Sotiriou\u00a0E, Tsentemeidou\u00a0A, Bakirtzi\u00a0K et al (2021) Psoriasis exacerbation after COVID-19 vaccination: a\u00a0report of 14\u00a0cases from a\u00a0single centre. J\u00a0Eur Acad Dermatol Venereol. https:\/\/doi.org\/10.1111\/jdv.17582","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"15","key":"4931_CR30","first-page":"107","volume":"27","author":"D Samotij","year":"2021","unstructured":"Samotij\u00a0D, Gawron\u00a0E, Szczech\u00a0J et al (2021) Acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis following COVID-19: a case report of a successful treatment with Infliximab in combination with Acitretin. Biologics 27(15):107\u2013113","journal-title":"Biologics"},{"issue":"7","key":"4931_CR31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","volume":"79","author":"M Gianfrancesco","year":"2020","unstructured":"Gianfrancesco\u00a0M, Hyrich\u00a0KL, Al-Adely\u00a0S et al (2020) Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis 79(7):859\u2013866","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"4931_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/annrheumdis-2020-218310","volume":"80","author":"FAI2R\/SFR\/SNFMI\/SOFREMIP\/CRI\/IMIDIATE consortium and contributors","year":"2020","unstructured":"FAI2R\/SFR\/SNFMI\/SOFREMIP\/CRI\/IMIDIATE consortium and contributors (2020) Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694\u00a0patients. Ann Rheum Dis 80(4):527\u2013538","journal-title":"Ann Rheum Dis"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04931-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04931-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04931-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T03:09:15Z","timestamp":1699931355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04931-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4931"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04931-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"assertion":[{"value":"7 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Demiri, M.\u00a0Abdo und A.\u00a0Tsianakas geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}